ARTICLE #1 FOR IMMEDIATE RELEASE
Recordable proteins as next-generation memory storage materials
Langmuir
Move over, compact discs, DVDs, and hard drives. Researchers in Japan report progress toward developing a new protein-based memory device that could provide an alternative to conventional magnetic and optical storage systems, which are quickly approaching their memory storage capacities. Their study is scheduled for the March 4 issue of ACS Langmuir, a bi-weekly journal.
Complex fibroadenomas have a low incidence of malignancy, so women with this condition can be more conservatively treated and avoid surgical biopsy, according to a new study by a team of researchers from the Hadassah-Hebrew University Medical Center in Jerusalem.
Diversity keeps you warm. At least that is true while you're having a shower in youth hostels. If you like, this sums up the research project just published by scientists from the Universities of Fribourg and Bonn. Their result is not as trivial as it sounds. Ultimately it shows that heterogeneity provides stability, whether this is in a shower, in power grids or even on the stock market.
Physical attractiveness is important in choosing whom to date. Good looking people are not only popular targets for romantic pursuits, they themselves also tend to flock together with more attractive others. Does this mean then that more attractive versus less attractive people wear a different pair of lens when evaluating others attractiveness"
From medicine to make-up, plastics to paper - hardly a day goes by when we don't use titanium dioxide.
Now researchers at the University of Leeds have developed a simpler, cheaper and greener method of extracting higher yields of one of this most useful and versatile of minerals.
Washington, DC — When the public considers competing arguments about a new technologys potential risks and benefits, people will tend to agree with the expert whose values are closest to their own, no matter what position the expert takes. The same will hold true for nanotechnology, a key study has found.
The cancer drug Avastin (bevacizumab) is used to treat advanced bowel cancer in combination with chemotherapy. This drug targets a protein called VEGF (vascular endothelial growth factor) that stimulates blood vessel growth. Avastin inhibits the growth of tumors by cutting off their blood supply, which deprives them of oxygen and other nutrients. In a small percentage of patients, however, Avastin can cause neurological side effects ranging from headaches and blurry vision to potentially fatal seizures and brain swelling.
Sitewide
